Condition : Rheumatoid Arthritis Interventions : Drug: Fostamatinib; Drug: Fostamatinib; Drug: Fostamatinib Sponsors : AstraZeneca; AstraZeneca Terminated - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Other: Placebo, then certolizumab pegol (CZP); Biological: Certolizumab pegol (CZP) Sponsor : UCB, Inc. Recruiting - verified July 2011

The purpose of this study is to examine the long term survivorship of the Scandinavian Total Ankle Replacement (STAR). Specifically, this study focuses on the revision and/or removal rate of any compo...

The purpose of this study is to examine the long term survivorship of the Scandinavian Total Ankle Replacement (STAR). Specifically, this study focuses on the revision and/or removal rate of any compo...

Condition : Rheumatoid Arthritis Interventions : Other: Placebo, then certolizumab pegol (CZP); Biological: Certolizumab pegol (CZP) Sponsor : UCB, Inc. Recruiting - verified July 2011

Conditions : Primary Arthrosis; Post Traumatic Arthritis; Rheumatoid Arthritis; Osteoarthritis Intervention : Device: Scandinavian Total Ankle Replacement System (STAR Ankle) Sponsors : Small Bone Inn...

Conditions : Primary Arthrosis; Post Traumatic Arthritis; Rheumatoid Arthritis; Osteoarthritis Intervention : Device: Scandinavian Total Ankle Replacement System (STAR Ankle) Sponsors : Small Bone Inn...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: placebo; Drug: tocilizumab [RoActemra/Actemra]; Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-L...

Condition : Juvenile Idiopathic Arthritis Interventions : Drug: CNTO 148 (Golimumab); Drug: Placebo; Drug: Methotrexate Sponsors : Janssen Research & Development, LLC; Schering-Plough (Ireland) Compan...

The purpose of this study is to evaluate 1 year extension study of the efficacy and the safety during treatment tocilizumab in patients completing treatment CWP-TCZ301 study with moderate to severe ac...